Cite
HARVARD Citation
Moloney, K. et al. (2012). Pasireotide (SOM230): a novel pituitary-targeted medical therapy for the treatment of patients with Cushing's disease. Expert review of endocrinology & metabolism. 7 (5), pp. 491-502. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Moloney, K. et al. (2012). Pasireotide (SOM230): a novel pituitary-targeted medical therapy for the treatment of patients with Cushing's disease. Expert review of endocrinology & metabolism. 7 (5), pp. 491-502. [Online].